家禽ワクチン市場レポート：2030年までの動向、予測、競合分析

家禽ワクチンの動向と予測

世界の家禽ワクチン市場は、2024年から2030年までのCAGRが5.1%で、2030年までに推定24億米ドルに達すると予想されます。この市場の主な促進要因は、家禽の健康と連動した需要の高まり、家禽における人獣共通感染症の流行増加、抗菌剤耐性を抑制するための意識の高まりと取り組みです。世界の家禽ワクチン市場の将来は、気管支炎、鳥インフルエンザ、ニューカッスル病、マレック病市場にビジネスチャンスがあり、有望視されています。

家禽ワクチン市場の洞察

Lucintelの予測では、弱毒生ワクチンは免疫期間が長く、伝染性気管支炎、伝染性滑液包炎、ニューカッスル病などの鳥類疾患に対する予防効果があるため、引き続き最大市場です。

この市場において、鳥インフルエンザは、世界各国で鳥類疾病の流行が増加していることから、引き続き最大の分野となると思われます。

北米は、家禽由来製品の消費の増加と、同地域における食品安全に対する消費者の意識の高まりにより、引き続き最大の地域となるであろう。

本レポートでは、以下の11の主要な質問に回答している：

• Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
• Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
• Q.3.今後成長が加速すると思われる地域とその理由は？
• Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
• Q.5.この市場におけるビジネスリスクと競合の脅威は？
• Q.6.この市場における新たな動向とその理由は？
• Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
• Q.8.この市場における新たな開発と、その開発をリードしている企業は？
• Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
• Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
• Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の家禽ワクチン市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界の家禽ワクチン市場動向（2018-2023）と予測（2024-2030）
• 製品別の世界の家禽ワクチン市場
  • 弱毒生ワクチン
  • 不活化ワクチン
  • 組換えワクチン
• 疾患タイプ別の世界の家禽ワクチン市場
  • 気管支炎
  • 鳥インフルエンザ
  • ニューカッスル病
  • マレック病
  • その他
• 用途別の世界の家禽ワクチン市場
  • ブロイラー
  • 産卵鶏
  • 種鶏

第4章 2018年から2030年までの地域別の市場動向と予測分析

• 地域別の世界の家禽ワクチン市場
• 北米の家禽ワクチン市場
• 欧州の家禽ワクチン市場
• アジア太平洋家禽ワクチン市場
• その他地域家禽ワクチン市場

第5章 競合の分析

• 製品ポートフォリオ分析
• 運用上の統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

• 成長機会分析
  • 製品別の世界の家禽ワクチン市場の成長機会
  • 疾患タイプ別の世界の家禽ワクチン市場の成長機会
  • 用途別の世界の家禽ワクチン市場の成長機会
  • 地域別の世界の家禽ワクチン市場の成長機会
• 世界の家禽ワクチン市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界の家禽ワクチン市場の能力拡大
  • 世界の家禽ワクチン市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 有力企業の企業プロファイル

• Bio-Vet
• Boehringer Ingelheim
• Ceva Animal Health
• Elanco
• Merck
• Phibro Animal Health
• Venkys
• Zoetis
• Vaxxinova International
• Venkys India

Poultry Vaccine Trends and Forecast

The future of the global poultry vaccine market looks promising with opportunities in the bronchitis, avian influenza, newcastle disease, and Marek's disease markets. The global poultry vaccine market is expected to reach an estimated $2.4 billion by 2030 with a CAGR of 5.1% from 2024 to 2030. The major drivers for this market are escalating demand for the poultry health coupled, rising prevalence of zoonotic diseases in poultry, and augmenting awareness and initiatives to curb antimicrobial resistance.

A more than 150-page report is developed to help in your business decisions.

Poultry Vaccine by Segment

The study includes a forecast for the global poultry vaccine by product, disease type, application, and region.

Poultry Vaccine Market by Product [Shipment Analysis by Value from 2018 to 2030]:

• Attenuated Live Vaccines
• Inactivated Vaccines
• Recombinant Vaccines

Poultry Vaccine Market by Disease Type [Shipment Analysis by Value from 2018 to 2030]:

• Bronchitis
• Avian Influenza
• Newcastle Disease
• Marek's Disease
• Others

Poultry Vaccine Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Broiler
• Layer
• Breeder

Poultry Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Poultry Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies poultry vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the poultry vaccine companies profiled in this report include-

• Bio-Vet
• Boehringer Ingelheim
• Ceva Animal Health
• Elanco
• Merck
• Phibro Animal Health
• Venkys
• Zoetis
• Vaxxinova International
• Venkys India

Poultry Vaccine Market Insights

Lucintel forecasts that attenuated live will remain the largest segment due to its longer immunity and protection against avian diseases such as infectious bronchitis, infectious bursal disease, and newcastle disease.

Within this market, avian influenza will remain the largest segment due to the rising prevalence of avian diseases among birds across all the countries in the world.

North America will remain the largest region due to growing consumption of poultry-derived products and escalating consumer awareness towards food safety in the region.

Features of the Global Poultry Vaccine Market

Market Size Estimates: Poultry vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Poultry vaccine market size by product, disease type, application, and region in terms of value ($B).

Regional Analysis: Poultry vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, disease types, applications, and regions for the poultry vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the poultry vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the poultry vaccine market size?

Answer: The global poultry vaccine market is expected to reach an estimated $2.4 billion by 2030.

Q.2 What is the growth forecast for poultry vaccine market?

Answer: The global poultry vaccine market is expected to grow with a CAGR of 5.1% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the poultry vaccine market?

Answer: The major drivers for this market are escalating demand for the poultry health coupled, rising prevalence of zoonotic diseases in poultry, and augmenting awareness and initiatives to curb antimicrobial resistance.

Q4. What are the major segments for poultry vaccine market?

Answer: The future of the poultry vaccine market looks promising with opportunities in the bronchitis, avian influenza, newcastle disease, and Marek's disease markets.

Q5. Who are the key poultry vaccine market companies?

Answer: Some of the key poultry vaccine companies are as follows:

• Bio-Vet
• Boehringer Ingelheim
• Ceva Animal Health
• Elanco
• Merck
• Phibro Animal Health
• Venkys
• Zoetis
• Vaxxinova International
• Venkys India

Q6. Which poultry vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that attenuated live will remain the largest segment due to its longer immunity and protection against avian diseases such as infectious bronchitis, infectious bursal disease, and newcastle disease.

Q7. In poultry vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to growing consumption of poultry-derived products and escalating consumer awareness towards food safety in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the poultry vaccine market by product (attenuated live vaccines, inactivated vaccines, and recombinant vaccines), disease type (bronchitis, avian influenza, newcastle disease, Marek's disease, and others), application (broiler, layer, and breeder), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Poultry Vaccine Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Poultry Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Poultry Vaccine Market by Product
  • 3.3.1: Attenuated Live Vaccines
  • 3.3.2: Inactivated Vaccines
  • 3.3.3: Recombinant Vaccines
• 3.4: Global Poultry Vaccine Market by Disease Type
  • 3.4.1: Bronchitis
  • 3.4.2: Avian Influenza
  • 3.4.3: Newcastle disease
  • 3.4.4: Marek's Disease
  • 3.4.5: Others
• 3.5: Global Poultry Vaccine Market by Application
  • 3.5.1: Broiler
  • 3.5.2: Layer
  • 3.5.3: Breeder

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Poultry Vaccine Market by Region
• 4.2: North American Poultry Vaccine Market
  • 4.2.2: North American Poultry Vaccine Market by Disease Type: Bronchitis, Avian Influenza, Newcastle disease, Marek's Disease, and Others
• 4.3: European Poultry Vaccine Market
  • 4.3.1: European Poultry Vaccine Market by Product: Attenuated Live Vaccines, Inactivated Vaccines, and Recombinant Vaccines
  • 4.3.2: European Poultry Vaccine Market by Disease Type: Bronchitis, Avian Influenza, Newcastle disease, Marek's Disease, and Others
• 4.4: APAC Poultry Vaccine Market
  • 4.4.1: APAC Poultry Vaccine Market by Product: Attenuated Live Vaccines, Inactivated Vaccines, and Recombinant Vaccines
  • 4.4.2: APAC Poultry Vaccine Market by Disease Type: Bronchitis, Avian Influenza, Newcastle disease, Marek's Disease, and Others
• 4.5: ROW Poultry Vaccine Market
  • 4.5.1: ROW Poultry Vaccine Market by Product: Attenuated Live Vaccines, Inactivated Vaccines, and Recombinant Vaccines
  • 4.5.2: ROW Poultry Vaccine Market by Disease Type: Bronchitis, Avian Influenza, Newcastle disease, Marek's Disease, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Poultry Vaccine Market by Product
  • 6.1.2: Growth Opportunities for the Global Poultry Vaccine Market by Disease Type
  • 6.1.3: Growth Opportunities for the Global Poultry Vaccine Market by Application
  • 6.1.4: Growth Opportunities for the Global Poultry Vaccine Market by Region
• 6.2: Emerging Trends in the Global Poultry Vaccine Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Poultry Vaccine Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Poultry Vaccine Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Bio-Vet
• 7.2: Boehringer Ingelheim
• 7.3: Ceva Animal Health
• 7.4: Elanco
• 7.5: Merck
• 7.6: Phibro Animal Health
• 7.7: Venkys
• 7.8: Zoetis
• 7.9: Vaxxinova International
• 7.10: Venkys India